•
Mar 31, 2016

CRISPR Therapeutics Q1 2016 Earnings Report

Total Revenue
$476K
EPS
-$0.459
Previous year: -$0.909
-49.5%
Gross Profit
-$5.54M
Previous year: -$1.16M
+375.6%
Cash and Equivalents
$201M

CRISPR Therapeutics

CRISPR Therapeutics